3/16
08:12 am
vtvt
vTv Therapeutics to Participate in the 38th Annual ROTH Conference [Yahoo! Finance]
High
Report
vTv Therapeutics to Participate in the 38th Annual ROTH Conference [Yahoo! Finance]
3/16
08:00 am
vtvt
vTv Therapeutics to Participate in the 38th Annual ROTH Conference
High
Report
vTv Therapeutics to Participate in the 38th Annual ROTH Conference
3/14
06:59 am
vtvt
vTv Therapeutics (VTVT) was upgraded by Evercore Inc to "strong-buy".
High
Report
vTv Therapeutics (VTVT) was upgraded by Evercore Inc to "strong-buy".
3/14
01:32 am
vtvt
High
Report
3/12
08:03 am
vtvt
vTv Therapeutics (VTVT) is now covered by Evercore Inc. They set an "outperform" rating on the stock.
Medium
Report
vTv Therapeutics (VTVT) is now covered by Evercore Inc. They set an "outperform" rating on the stock.
3/11
01:02 pm
vtvt
vTv Therapeutics (VTVT) had its "buy" rating reaffirmed by BTIG Research.
Low
Report
vTv Therapeutics (VTVT) had its "buy" rating reaffirmed by BTIG Research.
3/10
04:30 pm
vtvt
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]
3/10
04:20 pm
vtvt
VTv Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
Low
Report
VTv Therapeutics: Q4 Earnings Snapshot [Yahoo! Finance]
3/10
04:01 pm
vtvt
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Low
Report
vTv Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
3/4
12:34 am
vtvt
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737 [Yahoo! Finance]
Medium
Report
vTv Therapeutics (VTVT) Secures Global Partnership for PDE4 Inhibitor HPP737 [Yahoo! Finance]
2/28
05:16 am
vtvt
VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst [Seeking Alpha]
Medium
Report
VTv Therapeutics: Cadisegliatin's Phase 3 CATT1 Readout Is The Next Catalyst [Seeking Alpha]
2/13
08:29 am
vtvt
vTv Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
vTv Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/13
08:00 am
vtvt
vTv Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
vTv Therapeutics to Participate in Upcoming Investor Conferences
2/2
08:00 am
vtvt
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
Medium
Report
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
1/27
08:04 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock, up previously from $40.00.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock, up previously from $40.00.
1/24
06:29 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at Roth Mkm to a "strong-buy" rating.
1/22
05:08 pm
vtvt
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at Roth Mkm. They set a "buy" rating on the stock.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at Roth Mkm. They set a "buy" rating on the stock.
1/5
03:57 pm
vtvt
An Alzheimer's Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? [Yahoo! Finance]
Low
Report
An Alzheimer's Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? [Yahoo! Finance]
1/5
08:02 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at TD Cowen. They set a "buy" rating and a $67.00 price target on the stock.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at TD Cowen. They set a "buy" rating and a $67.00 price target on the stock.
1/5
07:03 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
Medium
Report
vTv Therapeutics (NASDAQ:VTVT) is now covered by analysts at Cowen Inc. They set a "buy" rating on the stock.
12/30
04:16 pm
vtvt
vTv Therapeutics (NASDAQ:VTVT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/27
01:05 am
vtvt
vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at
Wall Street Z
Low
Report
vTv Therapeutics (NASDAQ:VTVT) was upgraded by analysts at
Wall Street Z
12/24
07:01 pm
vtvt
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
Low
Report
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]
12/23
04:14 pm
vtvt
vTv Therapeutics (NASDAQ:VTVT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
vTv Therapeutics (NASDAQ:VTVT) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.